Our 1st webinar in our Journey for Small Molecules series offers a deep dive into how dissolution testing, when paired with cutting-edge chromatographic technologies and modern detection systems, accelerates formulation development and ensures the highest quality standards for small-molecule drugs.
Key Topics:
Understand the application of dissolution testing across various phases of the pharmaceutical development lifecycle
The role of dissolution testing in decision-making from preformulation through commercialisation
Key performance and analytical relevance of contemporary detectors, including DAD (Diode Array Detector), FLD (Fluorescence Detector), CAD (Charged Aerosol Detector), and QDa (Quadrupole Detector)
Angelo Spannagel, Head of Analytics, Eurofins PHAST Development GmbH & Co. KG
Dr. Xiao Yu Xie, Head of Laboratory, Eurofins PHAST Development GmbH & Co. KG